ADMA Biologics Inc (ADMA)
Payables turnover
Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost of revenue (ttm) | US$ in thousands | 195,502 | 177,944 | 171,639 | 169,273 | 162,260 | 151,071 | 133,774 | 118,814 | 105,881 | 94,743 | 87,440 | 79,769 | 76,009 | 67,569 | 62,232 | 61,291 | 53,872 | 49,933 | 46,928 | 39,504 |
Payables | US$ in thousands | 16,020 | 14,179 | 17,186 | 15,660 | 10,851 | 12,085 | 12,956 | 13,229 | 25,198 | 11,388 | 14,115 | 12,429 | 17,283 | 6,167 | 12,153 | 11,074 | 7,980 | 6,910 | 9,152 | 9,175 |
Payables turnover | 12.20 | 12.55 | 9.99 | 10.81 | 14.95 | 12.50 | 10.33 | 8.98 | 4.20 | 8.32 | 6.19 | 6.42 | 4.40 | 10.96 | 5.12 | 5.53 | 6.75 | 7.23 | 5.13 | 4.31 |
September 30, 2024 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $195,502K ÷ $16,020K
= 12.20
The payables turnover ratio for ADMA Biologics Inc has shown fluctuating trends over the past few quarters. The ratio indicates how efficiently the company is managing its accounts payable by measuring how many times a company pays off its average accounts payable balance during a period.
In the most recent quarter, ending September 30, 2024, the payables turnover ratio was 12.20, which suggests that the company paid off its accounts payable balances approximately 12.20 times during that quarter. This is a slight decrease compared to the previous quarter, where the ratio was 12.55.
Looking further back, the payables turnover ratio for ADMA Biologics Inc has ranged from a low of 4.20 to a high of 14.95 over the past few quarters. The higher the ratio, the more frequently the company is paying its suppliers, which may indicate good liquidity and strong supplier relationships. Conversely, a lower ratio may suggest that the company is taking longer to pay its bills, which could indicate cash flow issues or strained vendor relationships.
Therefore, based on the historical data provided, ADMA Biologics Inc has demonstrated fluctuations in its payables turnover ratio, reflecting varying levels of efficiency in managing its accounts payable. It would be important for stakeholders to monitor this ratio over time to assess the company's ability to effectively manage its working capital and vendor relationships.
Peer comparison
Sep 30, 2024